Mixed Open After Record Week

The markets opened mixed with the Dow slipping 10 points to 15,071 while Nasdaq rose 10 points to 3419.

On the upside

Molycorp (NYSE: MCP) widened first quarter losses but the results were better than expected.

Sequenom (Nasdaq: SQNM) widened losses for the first quarter but revenue more than doubled.

TheStreet upgraded Tesla Motors (Nasdaq: TSLA) to a Buy rating from Hold.

On the downside

Affymax (Nasdaq: AFFY) warned in its 10-Q filing that it may never achieve profitability and may not be able to continue operations if safety concerns over OMONTYS are not rectified by Takeda Pharmaceutical.

Pfizer (NYSE: PFE) has yet to decide whether it would continuing pursuing regulatory approval of Pain Therapeutics’ (Nasdaq: PTIE) abuse resistant pain treatment Remoxy. Remoxy was developed using Durect (Nasdaq: DRRX) technology.

Optimer Pharmaceuticals (Nasdaq: OPTR) widened first quarter losses more than expected.

  

In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 index added 2 points to 1628.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.